Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
Eli Lilly(LLY) stock is priced at $1,183.79, giving the company a market capitalization of 1.11T. It carries a P/E multiple of 39.11 and pays a dividend yield of 0.58%.
On 2026-09-24, Eli Lilly(LLY) stock traded between a low of $1,150.15 and a high of $1,197.75. Shares are currently priced at $1,183.79, which is +2.9% above the low and -1.2% below the high.
The Eli Lilly(LLY)'s current trading volume is 2.41M, compared to an average daily volume of 2.29M.
During the past year, Eli Lilly(LLY) stock moved between $712.05 at its lowest and $1,292.65 at its peak.
During the past year, Eli Lilly(LLY) stock moved between $712.05 at its lowest and $1,292.65 at its peak.
LLY News
Choosing between AbbVie (ABBV +0.01%) and Eli Lilly and Co (LLY +2.69%) requires weighing established income against explosive growth. Both companies lead the p...
...
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Eli Lilly and Company is running a new observational study in the U.A.E. that...
Analyst ratings
84%
of 32 ratingsMore LLY News
On Thursday, the U.S. Food and Drug Administration (FDA) approved Eli Lilly and Co.’s (NYSE:LLY) Onswik (insulin efsitora alfa-gobe), a once-weekly basal insuli...
The stock of Eli Lilly (LLY) is up 4% after the U.S. Food and Drug Administration (FDA) approved “Onswik,” a once-weekly insulin that treats adults with Type 2...
Eli Lilly (LLY) and Company announced the U.S. Food and Drug Administration approval of Onswik, a once-weekly basal insulin, indicated along with diet and exerc...
Eli Lilly (NYSE: LLY) agreed a research collaboration and licensing deal with InnoCare Pharma to pursue up to five new medicines. The partners plan to target s...
Key Points Famous investors don’t agree on everything, but these three see the value in this particular healthcare company. This player is generating blockbus...
InnoCare Pharma Ltd. ( (HK:9969) ) has provided an announcement. InnoCare Pharma has entered into a strategic research collaboration and license agreement with...
Key Points Eli Lilly has a deep pipeline in its core therapeutic area. Its next-gen obesity drug, retatrutide, posted excellent results in Phase 3 studies. T...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.